Mitochondrial Plasticity Promotes Resistance to Sorafenib and Vulnerability to STAT3 Inhibition in Human Hepatocellular Carcinoma.
Saved in:
| Title: | Mitochondrial Plasticity Promotes Resistance to Sorafenib and Vulnerability to STAT3 Inhibition in Human Hepatocellular Carcinoma. |
|---|---|
| Authors: | Pandit SK; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Sandrini G; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Merulla J; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Nobili V; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Wang X; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Zangari A; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Rinaldi A; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Shinde D; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Carbone GM; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Catapano CV; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland. |
| Source: | Cancers [Cancers (Basel)] 2021 Nov 30; Vol. 13 (23). Date of Electronic Publication: 2021 Nov 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
